HARMONY Platform

The platform that sees what others miss.

HARMONY is an AI platform built on a new branch of protein physics. It does not search for molecules that look like known drugs. It calculates, from first principles, which molecules will work — and why. The results speak for themselves.

90%

Of drug candidates fail in clinical trials. The leading cause: resistance mechanisms no existing tool can detect.

$2.6B

Average cost to bring one drug to market. HARMONY attacks this number at the source — before synthesis begins.

100%

Blind prediction record across every independent peer-reviewed dataset HARMONY has faced. 36 out of 36.

How It Works

Five steps from protein to drug candidate.

HARMONY does not require training data, historical drug databases, or prior knowledge of pharmacology. It starts with the protein's structure and derives everything else from physics.

1. Start With the Protein

HARMONY begins with the protein's 3D structure — validated across 2,991 human, viral, and bacterial proteins. No training data. No prior knowledge of what drugs target it.

2. Map Every Variant

Every possible mutation in the protein is scanned — thousands of variants — rapidly,. This is what makes HARMONY scalable across any target, any indication.

3. Calculate the Physics

For each variant, HARMONY calculates the physical signature that governs drug response — detecting the hidden resistance mechanisms that all competing tools miss. This step is what no other platform can perform.

4. Classify the Risk

Variants are ranked by their likelihood of causing drug resistance. The ones that will silently disable a medicine before it reaches patients are identified and flagged — before any money is spent on synthesis.

5. Design the Drug

HARMONY generates ranked drug candidates from physics. A 50-point safety filter runs inside every generation loop — blocking harmful compounds before they are proposed. Unsafe molecules cannot be produced by design.

The Problem

The tools being used today are blind to what matters most.

When a drug stops working — when a cancer patient develops resistance, when a cardiac treatment fails — it is almost never because the chemistry was wrong. It is because a protein changed in a way that existing tools could not see coming.

The Blind Spot

A single change in a protein's sequence — one letter out of thousands — can silently reorganize the entire protein in ways that make an approved drug useless. This happens far from where the drug binds, which is exactly why existing tools miss it.

The Cost of Missing It

When a cardiotoxic compound makes it through to late-stage trials before being flagged, the cost is approximately $200 million and four years of development — per compound, per miss. HARMONY catches these before a molecule is synthesized.

What HARMONY Found

Every protein carries a physical resonance signature that governs how it responds to a drug. InfiniGraph discovered this signature. The governing equations are derived from first principles — not learned from historical drug data.

Physics, Not Guesswork

HARMONY does not guess and get lucky. It computes and gets right. The same protein always produces the same result. That reproducibility is what makes HARMONY credible to regulators, partners, and the scientific community.

HARMONY doesn't guess. It computes — the same way an eclipse isn't predicted by watching the sky, but by calculating the orbits.

InfiniGraph — Platform Philosophy

The Difference

Every other AI platform learned from the past. HARMONY calculates the future.

The leading AI tools in drug discovery — including those built on AlphaFold — are trained to recognize molecules that resemble drugs that have already worked. That approach is powerful. But it is fundamentally limited to what has already been discovered. HARMONY operates from physics, which means it can find molecules that have never existed — and prove they should work, before anyone tests them.

Learn About Partnering